Montelukast 10 mg & Doxofyline 400 mg .. ... ..

MONTELUKE DX 
Montelukast (10mg) + Doxofyline (400mg)
Montelukast (10 mg) and Doxofylline (400 mg) are two different medications that are sometimes prescribed together to manage various respiratory conditions. Each medication serves a specific purpose in addressing symptoms associated with these conditions. Here's an overview of each component:

Montelukast (10 mg):

Purpose: Montelukast is a leukotriene receptor antagonist used to treat and manage asthma, allergic rhinitis (hay fever), and exercise-induced bronchoconstriction.
Mechanism of Action: It works by blocking the action of leukotrienes, which are inflammatory substances in the body that can trigger asthma and allergic reactions. Montelukast helps reduce airway inflammation, prevent asthma symptoms, and relieve allergic rhinitis symptoms.
Dosage: The typical dosage of montelukast for adults is 10 mg taken once daily, usually in the evening.
Doxofylline (400 mg):

Purpose: Doxofylline is a bronchodilator medication used to manage respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other airway disorders.
Mechanism of Action: Doxofylline relaxes and dilates the airways, making it easier to breathe. It also has anti-inflammatory properties that may help reduce airway inflammation.
Dosage: The specific dosage and frequency of doxofylline may vary depending on individual needs and the formulation of the medication.
Purpose of the Combination:

The combination of MONTELUKE DX  may be prescribed when a patient has a respiratory condition that involves both allergic and bronchoconstrictive components. This combination can provide comprehensive symptom relief.
Montelukast helps manage allergic symptoms, prevent asthma exacerbations, and reduce inflammation, while Doxofylline acts as a bronchodilator to improve airflow and ease breathing.
It's important to use this combination of medications only under the guidance and prescription of a healthcare provider. The specific dosages and duration of treatment will be determined based on the patient's medical history, symptoms, and individual response to the medications. Regular follow-up with a healthcare provider is typically recommended to assess the effectiveness of the treatment and make any necessary adjustments.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
sterisonline.com